(Q37803216)

23 August 2017

title

The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas (English)

1 reference

23 August 2017

1 reference

1 reference

Liu Hong

1

1 reference

23 August 2017

Yu Han

2

1 reference

23 August 2017

Shujun Li

3

1 reference

23 August 2017

Jianjun Yang

4

1 reference

23 August 2017

Jianyong Zheng

5

1 reference

23 August 2017

Hongwei Zhang

6

1 reference

23 August 2017

Qingchuan Zhao

7

1 reference

23 August 2017

Kaichun Wu

8

1 reference

23 August 2017

Daiming Fan

9

1 reference

23 August 2017

language of work or name

English

0 references

publication date

26 October 2010

1 reference

Expert Opinion on Biological Therapy

23 August 2017

published in

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

12

1 reference

23 August 2017

page(s)

1693-1701

1 reference

Epigenetics and miRNAs in human cancer

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Alternative splicing in cancer: noise, functional, or systematic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA expression profiles of esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Malignant biliary tract obstruction: evaluation and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNAs in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA involvement in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Molecular classification and novel targets in hepatocellular carcinoma: recent advancements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Progress and challenges in colorectal cancer screening and surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

miRNAs in colon and rectal cancer: A consensus for their true clinical value

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

let-7 microRNA functions as a potential growth suppressor in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Pdcd4, a colon cancer prognostic that is regulated by a microRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Role of anti-oncomirs miR-143 and -145 in human colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

miR-21 as a key regulator of oncogenic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

miR-21: a small multi-faceted RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

MicroRNA-based therapeutics for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

siRNA delivery using peptide transduction domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

miR-122, a paradigm for the role of microRNAs in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

The potential of modulating small RNA activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.532482

10.1517/14712598.2010.532482

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference